Labshake search
Citations for R&D Systems :
1 - 50 of 973 citations for 2 3 Cyclohexenyl Ethyltrimethoxysilane since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... 2 ng/mL of IL-2 and 3 ng/mL of TGFβ (R&D systems, 7666-MB-055)) conditions ...
-
bioRxiv - Cancer Biology 2022Quote: ... Digested cells were washed three times with PBS and resuspended in 2/3 Cultrex Type 2 (R&D Systems) and 1/3 Full Ad-DF+++ medium and plated in drops which were allowed to solidify for 30 minutes at 37°C after which they were overlayed with Full Ad-DF+++ medium ...
-
bioRxiv - Immunology 2024Quote: ... from 2-3 donors towards CXCL2 (R&D Systems, cat. 276-GB-010) and RARRES2 (R&D Systems ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Neuroscience 2024Quote: ... cultures were cotreated with 20 nM (2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide dihydrochloride (LM11a-31)(R&D Systems, Minneapolis, MN, USA, Cat no: 5046) or vehicle solution consisting of DMSO during application of 6-OHDA ...
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Neuroscience 2022Quote: ... and Neurotrophin-3 (NT-3, 20ng/ml, R&D systems) were used for neural differentiation between days 27 and 41 ...
-
bioRxiv - Developmental Biology 2020Quote: ... and the combination treatment of Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3). At Day2 ...
-
bioRxiv - Microbiology 2021Quote: ... DY210) were quantified in the supernatants from uninfected and SARS-CoV-2-infected Calu-3 cells by ELISA (R&D Systems), following manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3) were purchased from R&D Systems.
-
bioRxiv - Cancer Biology 2022Quote: ... human interleukin-3 (IL-3, 10 ng/mL, R&D Systems), human interleukin-6 (IL-6 ...
-
bioRxiv - Microbiology 2021Quote: ... TNF-α and MIF were quantified in the supernatants from uninfected and SARS-CoV-2-infected Calu-3 cells and monocytes by ELISA (R&D Systems), following manufacturer’s instructions ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs from healthy individuals were isolated and expanded in vitro for 7 days in the presence of 50 ng/ml of OKT-3 (Miltenyi) and 600 IU/ml IL-2 (R&D Systems) in AIM-V (Gibco ...
-
bioRxiv - Pathology 2020Quote: ... was measured immediately before injection and at 3 days after injection using a Mouse Lipocalin-2/NGAL Quantikine enzyme-linked immunosorbent assay (ELISA) Kit (R&D Systems) to ensure successful injection of folic acid ...
-
bioRxiv - Immunology 2023Quote: ... was pre-incubated with either 10 µl biotinylated SARS-CoV-2 spike protein (3 nM final concentration; R&D Systems cat# BT10549), or with 10 µl biotinylated irrelevant antigen (3 nM final concentration ...
-
bioRxiv - Microbiology 2021Quote: Human IL-29/IL-28B (IFN-lambda 1/3) concentration in SARS-CoV-2 infected epithelium basal media was quantified using ELISA technics following manufacturer’s recommendations (R&D systems, Minneapolis, USA). 100 μl of media was used for each point.
-
bioRxiv - Molecular Biology 2024Quote: ... 10 ng/mL mouse interleukin-3 (IL-3) (R&D Systems, 403-ML) and 10 ng/mL mouse interleukin-6 (IL-6 ...
-
bioRxiv - Molecular Biology 2020Quote: Randomly selected sections coming from ovarian tissue of least 3 different individuals were used for immunohistochemistry for Anti-active Caspase-3 (AC-3, 1:1000, AF-835, R&D Systems), γH2AX (1:250 IHC-00059 ...
-
bioRxiv - Bioengineering 2022Quote: ... α3 (MAB1345; R&D systems), β4 (NBP1-43369) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 3 (R&D Systems); coenzyme Q10 (CoQ) ...
-
bioRxiv - Cancer Biology 2023Quote: The blots were probed overnight at 4°C with monoclonal mouse anti-β-Catenin (2 µg/mL in Bovine Serum Albumin 3%, R&D Systems, Minneapolis, USA, #MAB1329), monoclonal rabbit anti-NDRG4 (1:1000 ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
bioRxiv - Developmental Biology 2024Quote: ... 3 µM CHIR (R&D Systems), 10 mM A83-01 (Tocris ...
-
bioRxiv - Developmental Biology 2024Quote: ... SSEA-3 (R&D Systems, MAB1434) and Alexa Fluor 594 conjugated SSEA-4 (BioLegend ...
-
bioRxiv - Pathology 2020Quote: ... goat polyclonal anti YM1/Chitinase-3 like 3 (R&D systems, Cat. No. AF2446, 1:400 dilution). Antigen retrieval of HIER2 (EDTA ...
-
bioRxiv - Cell Biology 2020Quote: ... 3 ng/mL mFGF2 (R&D Systems), 1xITS (Millipore Sigma)) ...
-
bioRxiv - Bioengineering 2020Quote: ... cleaved caspase-3 (R&D System, MAB835) (1:150 in goat serum ...
-
bioRxiv - Genomics 2022Quote: ... 3 µM CHIR99021 (R&D Systems 4423), and 1 µM PD0325901 (Sigma PZ0162) ...
-
bioRxiv - Immunology 2021Quote: ... or recombinant ficolin-3 (R&D systems) or human purified C1q (Comp Tech ...
-
bioRxiv - Immunology 2020Quote: ... IFNλ2/3 ELISA (R&D Systems DY1789B) and mouse IFNβ ...
-
bioRxiv - Cell Biology 2021Quote: ... syndecan-3 (R&D Systems Cat#: FAB3539A) and syndecan-4 (R&D Systems Cat# ...
-
bioRxiv - Genomics 2023Quote: ... 3 μM CHIR99021 (R&D Systems 4423) was added to the media ...
-
bioRxiv - Genetics 2023Quote: ... 10ng/ml IL-3 (R&D systems) and Ls513 cells were cultured in RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Immunology 2023Quote: ... anti-cleaved caspase-3 (R&D Systems), anti-RIPK3 (Abcam,) ...
-
bioRxiv - Genomics 2023Quote: ... 3 μM CHIR99021 (R&D Systems 4423), and 1 μM PD0325901 (Sigma PZ0162) ...
-
bioRxiv - Molecular Biology 2022Quote: ... 3 μM CHIR99021 (R&D Systems 4423), and 1 μM PD0325901 (Sigma PZ0162) ...
-
bioRxiv - Cell Biology 2024Quote: ... 3 IU/ml erythropoietin (R&D Systems) and 1% penicillin/streptomycin ...
-
bioRxiv - Bioengineering 2024Quote: ... type 2 (BME-2; R&D Systems; 3532-010-02), and dispensed in a 24-well plate to form 50 µL BME-2 domes for culture ...
-
bioRxiv - Molecular Biology 2020Quote: ... Rapamycin (Cat# 1912) and 3-Methyladenine (3-MA, Cat# 3977) were purchased from R&D Systems (Minneapolis, MN, USA). HSC70 (HSPA8 ...
-
bioRxiv - Immunology 2023Quote: ... and 50 U/mL Interleukin-2 (IL-2, R&D Systems). Pre-isolated NK cells were thawed and co-cultured at a 1:1 effector:target (E:T ...
-
bioRxiv - Cell Biology 2022Quote: ... Type 2 (BME-2) droplets (R&D Systems, Minneapolis, MN, USA) and covered under medium ...
-
bioRxiv - Molecular Biology 2024Quote: ... 10 ng/ml human interleukin-3 (IL-3) and 10 ng/ml human interleukin-6 (IL-6) (R&D Systems).
-
bioRxiv - Developmental Biology 2021Quote: ... 3 µM ZM306416 (R&D Systems, 2499/1) and 10 µM of SU5402 (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... at 3 μM and necrosulfonamide (R&D systems) at 1 μM ...
-
bioRxiv - Genomics 2021Quote: ... or 3 ng/ml TGFB (R&D Systems), or both ...